A Prospective Study Using Propensity Score Matching to Compare Long-term Survival Outcomes After Robotic-assisted, Laparoscopic or Open Liver Resection for Patients with BCLC Stage 0-A Hepatocellular Carcinoma.

医学 倾向得分匹配 肝细胞癌 阶段(地层学) 前瞻性队列研究 外科 入射(几何) 肝切除术 肝癌 内科学
作者
Peng Zhu,Wei Liao,Wan-Guang Zhang,Lin Chen,Chang Shu,Zhi-Wei Zhang,Zhi-Yong Huang,Yi-Fa Chen,Wan Yee Lau,Bi-Xiang Zhang,Xiao-Ping Chen
出处
期刊:Annals of Surgery [Ovid Technologies (Wolters Kluwer)]
被引量:1
标识
DOI:10.1097/sla.0000000000005380
摘要

To compare the short- and long-term outcomes of robot-assisted (RALR), laparoscopic (LLR), or open liver resection (OLR) in the treatment of BCLC stage 0-A hepatocellular carcinoma (HCC).Following the Balliol IDEAL classification, long-term oncological outcomes can be used to evaluate the value of minimally invasive techniques in the treatment of HCC, and to assess whether they should become a standard practice.Data from prospective cohorts of patients with BCLC stage 0-A HCC who underwent curative liver resection using OLR, LLR, or RALR at Tongji Hospital were reviewed. The short-term and long-term oncological outcomes of these three different surgical approaches after adequate follow-up were compared using propensity score matching to reduce selection bias.Of 369 patients included in this study (71, RALR; 141, LLR; and 157, OLR), 56 patients in each of the three groups were chosen for further comparison, after PSM. In the minimally invasive group (RALR+LLR), both the operative time and duration of Pringle's maneuver were significantly longer than those in the OLR group; however, the length of hospital stay was significantly shorter. There were no significant differences in the other intraoperative parameters and the incidence of postoperative complications among the three groups. HCC recurrence in the minimally invasive group when compared with the OLR group was characterized by a significantly higher proportion of single lesion or early stage HCC. However, there were no significant differences in the 5-year disease-free survival (DFS) (63.8%, 54.4%, and 50.6%) or overall survival rates (80.8%, 78.6%, and 75.7%, respectively) among the three groups. Clinically significant portal hypertension (CSPH) was the only risk factor that negatively affected the 5-year DFS rate. Multivariate Cox regression analysis showed that CSPH, serum alpha-fetoprotein level (≥400 ng/ml), and Edmondson-Steiner grading (III+IV) were independent risk factors for poor long-term survival.Both robotic and laparoscopic hepatectomies were safe and effective for patients with BCLC stage 0-A HCC when compared with open hepatectomy.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
申锴发布了新的文献求助10
刚刚
刚刚
科研通AI6应助www采纳,获得10
刚刚
汉堡包应助wzh采纳,获得10
刚刚
表示肯定的羊完成签到,获得积分20
刚刚
awen完成签到,获得积分10
1秒前
善学以致用应助冷酷严青采纳,获得10
1秒前
852应助冷酷严青采纳,获得10
1秒前
1秒前
爆米花应助柒八染采纳,获得10
1秒前
卡皮巴拉完成签到,获得积分10
1秒前
bkagyin应助开心人达采纳,获得10
1秒前
科研通AI6应助争取少吃点采纳,获得10
1秒前
chen发布了新的文献求助10
1秒前
研友_LJaro8发布了新的文献求助20
2秒前
2秒前
情怀应助忧心的山槐采纳,获得10
2秒前
英吉利25发布了新的文献求助10
3秒前
奔流的河完成签到,获得积分10
3秒前
俊逸的蜜蜂发布了新的文献求助260
4秒前
量子星尘发布了新的文献求助10
4秒前
4秒前
4秒前
在水一方应助xin采纳,获得10
5秒前
小马甲应助帅气一刀采纳,获得10
5秒前
鸡鱼蚝完成签到,获得积分10
5秒前
思源应助Muggle采纳,获得10
5秒前
5秒前
6秒前
简单绯完成签到,获得积分10
6秒前
Battery-Li完成签到,获得积分10
7秒前
7秒前
天天快乐应助锂离子采纳,获得10
7秒前
fanfan完成签到 ,获得积分10
7秒前
粟米发布了新的文献求助10
7秒前
好好吃饭完成签到,获得积分10
8秒前
今后应助asadman_W采纳,获得10
8秒前
8秒前
12334发布了新的文献求助10
9秒前
czcmh应助朱祥龙采纳,获得30
9秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
Binary Alloy Phase Diagrams, 2nd Edition 8000
Encyclopedia of Reproduction Third Edition 3000
Comprehensive Methanol Science Production, Applications, and Emerging Technologies 2000
From Victimization to Aggression 1000
Exosomes Pipeline Insight, 2025 500
Red Book: 2024–2027 Report of the Committee on Infectious Diseases 500
热门求助领域 (近24小时)
化学 材料科学 生物 医学 工程类 计算机科学 有机化学 物理 生物化学 纳米技术 复合材料 内科学 化学工程 人工智能 催化作用 遗传学 数学 基因 量子力学 物理化学
热门帖子
关注 科研通微信公众号,转发送积分 5647530
求助须知:如何正确求助?哪些是违规求助? 4773705
关于积分的说明 15039847
捐赠科研通 4806303
什么是DOI,文献DOI怎么找? 2570208
邀请新用户注册赠送积分活动 1527046
关于科研通互助平台的介绍 1486132